153 results
Page 4 of 8
424B5
2bchall0jhxnhzabwy
9 Feb 11
Prospectus supplement for primary offering
12:00am
424B5
gxstc3ub k7p1of8uh
5 Nov 10
Prospectus supplement for primary offering
12:00am
424B5
2fzt32kp
5 Nov 10
Prospectus supplement for primary offering
12:00am
CORRESP
83ty4ovuko
10 Sep 10
Correspondence with SEC
12:00am
DEFM14A
b9emm6o
8 Jun 10
Proxy related to merger
12:00am
DEFA14A
EX-10.3
fn8rahfn
6 Apr 10
Additional proxy soliciting materials
12:00am
8-K
EX-2.1
5qg8rzvbdqo
6 Apr 10
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.3
f80wwi3sdva
6 Apr 10
Entry into a Material Definitive Agreement
12:00am
DEFA14A
EX-2.1
mjufdpap9enen4nr8xbp
6 Apr 10
Additional proxy soliciting materials
12:00am
424B5
dbvs1mec7f2xacoe
14 Jan 10
Prospectus supplement for primary offering
12:00am
424B5
ax3z5b1or4y4x2e8kanj
24 Dec 09
Prospectus supplement for primary offering
12:00am
424B5
b3lkh
11 Jun 09
Prospectus supplement for primary offering
12:00am
S-8
26emb2vvpyua j6t
19 Sep 08
Registration of securities for employees
12:00am
8-K
EX-10.1
a4srl9f
13 Jun 08
Nastech Initiates New Corporate Direction with Name Change to MDRNA, Inc. and Appointment of J. Michael French as Chief Executive Officer
12:00am